Investment Ratings - BYD: Buy [7][18] - XPeng: Buy [8][20] - Nio: Neutral [10][21] - Hesai: Buy [15][22] - Zhongsheng: Neutral [17][23] Core Insights - Demand & Stimulus: Management across the industry believes that government support will continue, and effective per vehicle purchase costs will not rise for consumers. Alternative forms of stimulus may emerge if trade-in programs diminish [1][14] - Industry Competition: Competition is expected to persist over the next 2-3 years, shifting focus from pricing to value. OEMs will launch new models with higher configurations at attractive prices, with market dynamics playing a larger role in pricing than government regulations [2][10] - Overseas Operations: OEMs with international exposure have reported strong overseas sales, with localized production capacities being developed to mitigate geopolitical trade tensions [3][7] - Autopilot Development: Autopilot technology is gaining traction, with improvements in functions and hardware. LiDAR adoption is increasing, and some OEMs are equipping multiple LiDARs per vehicle as they progress towards Level 3 capabilities [4][11] Summary by Company BYD - Sales Volume: BYD achieved total sales of 2.1 million units in 1H25, a 33% year-over-year increase. Inventory months decreased from 3 months in April to 2.2 months in June [8] - Overseas Expansion: BYD's overseas sales reached 464,000 units in 1H25, a 128% year-over-year increase, with multiple factories set to begin mass production [8] - Autopilot Features: The "God's Eye" autopilot system was launched, with plans for city memory autopilot capabilities by year-end [8] XPeng - Profitability Goals: XPeng aims for non-GAAP net profit break-even in 4Q25, with expectations of improved vehicle gross margins [11] - New Product Launches: XPeng plans to launch several new models, including a large EREV SUV in 4Q25, and has recently launched the G7 featuring advanced AI technology [8][11] - Sales Performance: XPeng's management is optimistic about maintaining competitive pricing while focusing on value [11] Nio - Sales Growth: Nio reported a total sales volume of 72,000 units in 2Q25, a 26% year-over-year increase, driven by new model launches [10] - Gross Margin Targets: Nio aims for a blended vehicle gross margin of over 15% by the end of 2025 [12] - Operational Efficiency: Nio is implementing operational expense reductions to improve R&D efficiency and overall profitability [10][12] Leapmotor - Sales Volume: Leapmotor achieved 222,000 units in sales volume in 1H25, a 156% year-over-year increase, with ambitious targets for future launches [14] - New Model Pipeline: The company plans to launch multiple new models in 2H25 and 2026, targeting a total delivery of 1 million units by 2026 [14] Hesai - Revenue Guidance: Hesai expects 2025 revenue between RMB 3-3.5 billion, with a gross margin around 40% [16] - Market Recognition: The company is gaining recognition from both domestic and global OEMs, with increased LiDAR adoption in the industry [16] - Production Capacity: Hesai targets an annual production capacity of 2 million units by the end of 2025 [16] Zhongsheng - Sales Performance: Zhongsheng maintains an annual sales volume target of 480,000-500,000 units, with a focus on AITO brand operations [19] - After-sales Services: The company anticipates growth in revenue from after-sales services, driven by adjustments in store operations [19]

Investment Rating - The report maintains a Neutral rating for iFlytek (002230.SZ) with a 12-month price target of Rmb54.00, indicating an upside potential of 14.9% from the current price of Rmb46.98 [1][10][26]. Core Insights - iFlytek's 2Q25 revenue guidance is expected to grow by 10% to 15% year-over-year, with a midpoint growth of 11%, which is 7% below previous estimates. The company reported a net loss in 2Q25, attributed to increased spending on AI model development [1][18]. - The company has launched new AI models, including iFlytek Spark LLM V4.0 Turbo and a new reasoning model, which are expected to enhance its project wins in AI software [2][18]. - iFlytek secured a new project worth Rmb232 million from the QinHuangDao government for AI model training and management, indicating strong momentum in AI monetization [2][18]. Financial Summary - Revenue projections for iFlytek are revised downwards for 2025-2027, with expected revenues of Rmb28,797 million in 2025, Rmb32,648 million in 2026, and Rmb38,794 million in 2027, reflecting a decrease of 1%, 3%, and 5% respectively from previous estimates [19][20]. - The report anticipates a net income of Rmb1,100 million in 2025, Rmb2,029 million in 2026, and Rmb3,316 million in 2027, with a downward revision of 24%, 23%, and 27% respectively [19][20]. - The operating margin is expected to improve from 2.3% in 2025 to 5.2% in 2026, and further to 8.1% in 2027, indicating a gradual recovery in profitability [11][20]. Valuation Metrics - The report sets a target price based on a valuation of 4.1x 2026E EV/Sales, which aligns with peer averages in the software sector. The implied 2026E P/E ratio is projected at 60x, consistent with the company's trading range since 2019 [20][26]. - Key financial ratios include a projected P/E of 98.7x for 2025, decreasing to 32.7x by 2027, and a P/B ratio of 5.8x in 2025, declining to 4.7x in 2027 [10][11].

Investment Rating - The report maintains a "Buy" rating for Asymchem, Kangji Medical, Weigao, Angelalign, and Hygeia, while Tigermed, WuXi XDC, WuXi Biologics, and Frontage are rated as "Neutral" [11][15][18][27][36]. Core Insights - The report highlights a recovery in the healthcare sector, particularly in the CDMO segment, with expectations for earnings resilience driven by new order growth and demand from both US and EU markets, as well as from Chinese biotech licensing [2][3]. - The Medtech sector is anticipated to see clearer recovery in the second half of 2025, supported by normalized hospital activity and new product contributions [3]. - The report emphasizes the importance of monitoring pricing competition and consumption recovery signals in the services sector, particularly in consumer-related categories [4]. Summary by Sections CRO/CDMO - Earnings are expected to remain resilient, especially for companies with exposure to late-stage development and manufacturing projects [2]. - Key investor focus areas include new order growth, client behavior shifts amid policy uncertainties, and pricing and margin recovery [2][13]. - EPS estimates have been revised upward by an average of 1.3% to 1.4% for 2025-2027, with target prices adjusted by an average of 4% [1]. Medtech - Recovery is expected to materialize more clearly in the second half of 2025, with key areas to watch including the pace of VBP rollout and surgical volume trends [3]. - Companies like Weigao and Kangji are ramping up new product launches and global expansions, despite some tariff-related uncertainties [3]. Services - Reimbursement control and DRG/DIP pressure are likely to persist, impacting pricing and volumes [4]. - The report notes a cautious outlook for M&A activity, with companies like Hygeia becoming more positive while others remain cautious [9]. Financial Estimates - The report provides detailed financial estimates for various companies, indicating expected sales growth and net income projections for FY25 and beyond [14][19]. - For instance, WuXi Apptec is projected to achieve a revenue growth of 10-15% for FY25, while Asymchem anticipates double-digit revenue growth alongside margin improvements [19]. Target Price Changes - Target prices for several companies have been adjusted, with Asymchem's target price increased to HK$85.5, reflecting a 13% change [11][15]. - WuXi Biologics' target price is set at HK$25.6, based on a 12-month forward P/E of 22x [15][31]. Backlog and Order Trajectory - The report includes a detailed analysis of backlog and new order trajectories for key players in the CRO/CDMO space, indicating significant year-on-year growth in sales and backlog for companies like WuXi Apptec and WuXi Biologics [17].

Investment Rating - The report does not provide a specific investment rating for Huace Navigation (300627.SZ) as it is categorized as "Not Covered" [1]. Core Insights - Huace Navigation is a leading provider of MEO satellite navigation, positioning, and mapping services in China, focusing on enterprise clients and expanding applications into various sectors including autonomous driving and robotics [1][3]. - The global LEO satellite market is expected to grow significantly, with a total addressable market (TAM) projected to increase from US$15 billion in 2024 to US$108 billion by 2035, indicating a favorable environment for companies like Huace [2]. Summary by Sections Product Development - Huace is expanding its product line to capture new use cases, including the launch of the AA10 airborne measuring system that integrates LiDAR and industrial cameras, enhancing its geospatial information offerings [4][7]. - The company is also developing autonomous driving solutions, such as the P-Box for Baidu Apollo Go's robotaxi, which provides accurate geospatial data for vehicles [7]. Market Expansion - Huace aims to expand its satellite navigation solutions into overseas markets, having established a strong distribution network across regions including Southeast Asia, Europe, and South America [8]. - In 2024, revenues from non-China markets increased by 30% year-on-year to RMB 937 million, accounting for 29% of total revenue, with expectations for continued growth in overseas contributions [8]. Competitive Advantages - Huace's competitive edges include in-house algorithm development, competitive pricing, and accumulated expertise in MEO applications, which enhance its market position [9]. - The company's GNSS analysis platform offers high precision and data compatibility, further solidifying its competitive stance in the satellite navigation market [9].

11 July 2025 | 10:28AM HKT Asia Pacific: Extended Negotiation Period For US Tariffs Prolongs Uncertainty Bottom line: Letters from US President Trump to at least 22 countries—the majority of which are in Asia—indicate that the US plans to raise tariff levels on August 1, to levels generally similar to the 'reciprocal' tariffs originally announced April 2nd. In our view, this effectively marks an extension of the tariff/trade negotiating period from July 9 to August 1. President Trump also announced a 50% ta ...

Investment Rating - The report maintains a moderately positive outlook for Asian equity markets, forecasting a 9% USD price return over the next 12 months with a revised MXAPJ index price target of 700, which is 3% above the previous target of 680 [3][47][54]. Core Insights - The macro risk environment has improved, with reduced US economic policy uncertainty and expectations of Fed rate cuts, which are likely to support regional equities [4][32]. - The tariff environment remains fluid, with potential impacts on GDP growth and earnings forecasts, but the overall growth impact may not be as negative as previously feared [14][19]. - Earnings growth is expected to be the dominant driver of returns, with forecasts of 9% and 10% EPS growth for 2025 and 2026, respectively [48][52]. Summary by Sections Current Conditions - The macro risk environment has improved due to moderated US economic policy uncertainty, eased financial conditions, and firm activity data, leading to a 25% rebound in the MXAPJ index [4][5][6]. Tariffs - The tariff situation is expected to influence equity performance, with potential higher rates but greater certainty. The final tariff rates may differ from current expectations, impacting GDP growth and earnings forecasts [14][15][19]. Rates - The Fed is expected to begin cutting rates in September, with a total of five cuts anticipated by mid-2026, which should support regional equities through a weaker dollar [32][33][36]. Returns - The report anticipates a wide dispersion of expected returns across markets, with a forecasted 9% USD price return over 12 months based on earnings growth and a revised index target [47][49][54]. Allocations - The report emphasizes North Asia, maintaining overweights in China, Japan, and Korea, while downgrading Malaysia to underweight. Sector upgrades include capital goods and tech hardware, while autos and consumer staples are downgraded [59][60][69][75].

Investment Rating - The report maintains an "Overweight" (OW) stance on both A-shares and Offshore China despite trimming the CSI300 12-month target from 4600 to 4400 due to lower earnings growth and a more conservative valuation [1][44]. Core Insights - The anticipated nationwide childbirth subsidy program in China is expected to boost GDP growth by 25 basis points (bp) annualized in the second half of 2025, although it may slightly lower GDP growth in 2026 [1]. - The report indicates a significant inflow of US$3.4 billion into Southbound investments this week, with Northbound holdings data suggesting US$3.3 billion inflows in the second quarter of 2025 [1][45]. - The 12-month forward price-to-earnings (P/E) ratios for MXCN and CSI300 are projected at 11.8x and 13.1x, respectively, with earnings per share (EPS) growth estimates of 5% for 2025 and 14% for 2026 for MXCN, and 21% for 2025 and 14% for 2026 for CSI300 [8][43]. Summary by Sections Performance - The report highlights that Real Estate and GARP (Growth at a Reasonable Price) sectors outperformed, while Materials and ROE (Return on Equity) lagged [7]. Earnings and Valuations - The report revises the earnings growth forecast for 2025/26 to 9% and 10% respectively, with a consensus EPS growth of 5% for 2025 and 14% for 2026 [43][66]. Policies and News - Onshore exchanges have issued final regulations on program trading, indicating a regulatory push towards high-quality development in the securities industry [4]. Market Update - The report notes that trade policy uncertainty has eased, and financial conditions have loosened, which may positively impact market performance [35][39]. Sectoral Insights - The report suggests that sectors such as Internet/Media/Entertainment, Consumer Retail & Durables, and Tech Hardware are positioned for growth, while Energy, Chemicals, and Utilities are underweight [44][67].

Investment Rating - The report maintains a positive outlook on the S&P 500 index, with price return forecasts raised to 6,600 points by the end of the year and 6,900 points by mid-next year, indicating a potential increase of approximately 10% from current levels [17][18]. Core Insights - The anticipated increase in tariffs by the U.S. could raise the effective tariff rate by about 5 percentage points, with a potential realization of approximately 3 percentage points by the end of the year [1][3]. - The report highlights a pause in the trend of a weakening dollar, influenced by foreign holdings of U.S. assets and potential economic data releases that could lead to a stronger dollar [5][7]. - There is a divergence in profit growth predictions for 2026, with Goldman Sachs expecting an acceleration in economic activity and a search for underperforming stocks as tariff uncertainties dissipate [19]. Summary by Sections Tariff Actions and Economic Impact - The U.S. has announced potential tariffs ranging from 25% to 50% on various countries, with specific implications for sectors like copper and electronics, which could see significant impacts on import values [2][3][4]. - The tariffs on Brazilian goods are set at 50%, but the overall impact on Brazil's GDP growth is estimated to be around 0.4 percentage points, indicating limited effects on the broader economy [15]. Market Predictions and Economic Conditions - The S&P 500 index's price return forecast has been adjusted upwards due to expectations of Federal Reserve rate cuts, lower bond yields, and improved fundamentals for large-cap stocks [17][19]. - The current market breadth is narrow, with a potential for a 10% correction in the next 6-12 months, suggesting caution for investors [18]. Sector Recommendations - The report recommends focusing on specific growth sectors such as software, services, and media entertainment, while also considering cyclical lagging industries like materials and utilities as the Fed begins to cut rates [20]. - Alternative asset management companies are noted as underperforming compared to bank stocks, with potential capital shifts towards private equity if the stock market remains resilient [20].

Investment Rating - The report maintains a "Buy" rating for Foxconn Industrial Internet (FII) with a revised target price of Rmb31.11, reflecting an upside potential of 17.9% from the current price of Rmb26.38 [16][17]. Core Insights - FII's 2Q25 net income guidance is between Rmb6.7 billion and Rmb6.9 billion, with a midpoint of Rmb6.8 billion, representing a 31% quarter-over-quarter increase and a 50% year-over-year increase [1]. - The company is experiencing significant growth in cloud computing revenues, projected to exceed 50% year-over-year, and AI server revenues are expected to grow over 60% year-over-year [1]. - FII's revenues from cloud service providers (CSPs) increased by over 150% year-over-year in 2Q25, and revenues from 800G switches are projected to be three times higher than in 2024 [1]. - The report anticipates a compound annual growth rate (CAGR) of 29% for net income from 2025 to 2027, with AI server revenues expected to rise from 29% in 2024 to 68% by 2027 [1]. Financial Projections - The report revises net income estimates upward by 3%, 4%, and 6% for 2025, 2026, and 2027 respectively, due to higher revenue expectations [5]. - FII's revenue projections for 2025E, 2026E, and 2027E are Rmb850.1 billion, Rmb1,130.6 billion, and Rmb1,274.5 billion respectively, reflecting increases of 5%, 10%, and 9% from previous estimates [8]. - The gross profit (GP) for 2025E is revised to Rmb49.9 billion, with operating profit (OP) at Rmb31.4 billion and net income at Rmb27.6 billion [8]. Market Position and Competitive Analysis - FII is positioned as a leading supplier in the AI server market, particularly in rack-level AI servers, supported by a comprehensive supply chain and global production capabilities [5][9]. - The target price is based on a price-to-earnings (P/E) multiple of 16x for 2026E, reflecting a market re-rating on AI servers [10][15].

Investment Rating - The investment rating for HG Tech is "Buy" with an updated 12-month target price of Rmb56, revised from Rmb53, based on a 22x 2026E P/E [1][2][14]. Core Insights - HG Tech pre-announced its 2Q net profit range of Rmb480 million to Rmb540 million, with a mid-point of Rmb510 million, representing a 52% year-over-year increase and exceeding expectations [1]. - The strong profit performance is expected to alleviate investor concerns regarding the profitability of optical transceivers, with key catalysts anticipated in the second half of 2025, including progress in penetrating US markets and domestic demand outlook [1][14]. - The company is positioned for robust long-term growth driven by the AI infrastructure cycle, overseas expansion, and new market penetration [1]. Revenue and Profit Estimates - Revenue estimates for 2025-2026 have been revised upward by 3% to 4.6%, leading to a net profit estimate increase of 4% to 8% [2]. - New revenue projections for 2025, 2026, and 2027 are Rmb15,815 million, Rmb19,233 million, and Rmb22,971 million respectively, reflecting a 4.6% increase for 2025 and 2026, and a 3.0% increase for 2027 compared to previous estimates [6]. - Net income estimates for 2025, 2026, and 2027 are Rmb1,830 million, Rmb2,579 million, and Rmb3,130 million respectively, with increases of 8%, 6%, and 4% compared to prior estimates [6]. Business Segments and Growth Drivers - HG Tech's business segments include optical transceivers, sensors, telecom equipment, and laser tools, with a focus on high-end optical transceivers (800G and 400G modules) expected to drive margin improvement and net profit growth [14]. - The revenue mix for 2024 is projected to be 34% from laser tools, 3% from networking, and 63% from sensors, with shifts expected in 2025 and 2026 [13][11]. - The company is expected to benefit from the increasing attach ratio of optical transceivers, supporting better growth sustainability [1].